Fuster, Daniel G

Anderegg, Manuel A; Olinger, Eric G; Bargagli, Matteo; Geraghty, Rob; Taylor, Lea; Nater, Alexander; Bruggmann, Rémy; Sayer, John A; Vogt, Bruno; Schaller, André; Fuster, Daniel G (2024). Prevalence and characteristics of genetic disease in adult kidney stone formers. Nephrology, dialysis, transplantation, 39(9), pp. 1426-1441. Oxford University Press 10.1093/ndt/gfae074

Stritt, Kevin; Fuster, Daniel G; Dhayat, Nasser A; Bonny, Olivier; Faller, Nicolas; Christe, Andreas; Taha, Anas; Ochs, Vincent; Ortlieb, Niklas; Roth, Beat (2024). Risk factors for asymptomatic kidney stone passage in adults with recurrent kidney stones. (In Press). Clinical journal of the American Society of Nephrology, 19(9), pp. 1130-1137. Lippincott, Williams & Wilkins 10.2215/CJN.0000000000000496

Legay, Constance; Haeusermann, Tanja; Pasquier, Jérôme; Chatelan, Angeline; Fuster, Daniel G; Dhayat, Nasser; Seeger, Harald; Ritter, Alexander; Mohebbi, Nilufar; Ernandez, Thomas; Stoermann, Catherine; Buchkremer, Florian; Segerer, Stephan; Wuerzner, Grégoire; Ammor, Nadia; Roth, Beat; Wagner, Carsten A; Bonny, Olivier; Bochud, Murielle (2023). Differences in the food consumption between kidney stone formers and non-formers in the Swiss Kidney Stone Cohort. Journal of renal nutrition, 33(4), pp. 555-565. Elsevier 10.1053/j.jrn.2023.04.007

Bargagli, Matteo; Vetsch, Andri; Anderegg, Manuel A; Dhayat, Nasser A; Huynh-Do, Uyen; Faller, Nicolas; Vogt, Bruno; Ferraro, Pietro Manuel; Fuster, Daniel G (2023). Tolvaptan treatment is associated with altered mineral metabolism parameters and increased bone mineral density in ADPKD patients. Nephrology, dialysis, transplantation, 38(7), pp. 1645-1654. Oxford University Press 10.1093/ndt/gfac298

Fuster, Daniel G; Bonny, Olivier; Roth, Beat (2023). Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence. Reply. The New England journal of medicine, 388(21), pp. 2015-2016. Massachusetts Medical Society 10.1056/NEJMc2304100

Ferraro, Pietro Manuel; Bargagli, Matteo; Faller, Nicolas; Anderegg, Manuel A; Huynh-Do, Uyen; Vogt, Bruno; Gambaro, Giovanni; Fuster, Daniel G (2023). The role of urinary supersaturations for lithogenic salts in the progression of autosomal dominant polycystic kidney disease. Journal of nephrology JN, 36(4), pp. 1011-1018. Wichtig Editore 10.1007/s40620-022-01540-5

Dhayat, Nasser A; Bonny, Olivier; Roth, Beat; Christe, Andreas; Ritter, Alexander; Mohebbi, Nilufar; Faller, Nicolas; Pellegrini, Lisa; Bedino, Giulia; Venzin, Reto M; Grosse, Philipp; Hüsler, Carina; Koneth, Irene; Bucher, Christian; Del Giorno, Rosaria; Gabutti, Luca; Mayr, Michael; Odermatt, Urs; Buchkremer, Florian; Ernandez, Thomas; ... (2023). Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence. New England journal of medicine NEJM, 388(9), pp. 781-791. Massachusetts Medical Society MMS 10.1056/NEJMoa2209275

Mueller, Livia; Moser, Michel; Prazak, Josef; Fuster, Daniel G; Schefold, Joerg C; Zuercher, Patrick (2023). Metformin's Role in Hyperlactatemia and Lactic Acidosis in ICU Patients: A Systematic Review. Pharmacology, 108(3), pp. 213-223. Karger 10.1159/000528252

Augustynek, Bartlomiej; Gyimesi, Gergely; Dernič, Jan; Sallinger, Matthias; Albano, Giuseppe; Klesse, Gabriel J; Kandasamy, Palanivel; Grabmayr, Herwig; Frischauf, Irene; Fuster, Daniel G; Peinelt, Christine; Hediger, Matthias A; Bhardwaj, Rajesh (2022). Discovery of novel gating checkpoints in the Orai1 calcium channel by systematic analysis of constitutively active mutants of its paralogs and orthologs. Cell calcium, 105, p. 102616. Elsevier 10.1016/j.ceca.2022.102616

Verouti, Sophia N; Pujol-Giménez, Jonai; Bermudez-Lekerika, Paola; Scherler, Laeticia; Bhardwaj, Rajesh; Thomas, Aurélien; Lenglet, Sébastien; Siegrist, Mark; Hofstetter, Willy; Fuster, Daniel G; Hediger, Matthias A; Escher, Geneviève; Vogt, Bruno (2022). The Allelic Variant A391T of Metal Ion Transporter ZIP8 (SLC39A8) Leads to Hypotension and Enhanced Insulin Resistance. Frontiers in physiology, 13, p. 912277. Frontiers Research Foundation 10.3389/fphys.2022.912277

Anderegg, Manuel A; Gyimesi, Gergely; Ho, Manh Tin; Hediger, Matthias A; Fuster, Daniel G (2022). The Less Well-Known Little Brothers: The SLC9B/NHA Sodium Proton Exchanger Subfamily—Structure, Function, Regulation and Potential Drug-Target Approaches. Frontiers in physiology, 13, p. 898508. Frontiers Research Foundation 10.3389/fphys.2022.898508

Sekulic-Jablanovic, Marijana; Paproth, Jessica; Sgambato, Cinzia; Albano, Giuseppe; Fuster, Daniel G; Bodmer, Daniel; Petkovic, Vesna (2022). Lack of NHE6 and Inhibition of NKCC1 Associated With Increased Permeability in Blood Labyrinth Barrier-Derived Endothelial Cell Layer. Frontiers in cellular neuroscience, 16(862119), p. 862119. Frontiers Research Foundation 10.3389/fncel.2022.862119

Kucharczyk, Patrycja; Albano, Giuseppe; Deisl, Christine; Wueest, Stephan; Konrad, Daniel; Fuster, Daniel G (26 March 2022). Thiazides induce glucose intolerance through inhibition of mitochondrial carbonic anhydrase 5b in β-cells (bioRxiv). Cold Spring Harbor Laboratory 10.1101/2022.03.23.485566

Anderegg, Manuel; Liu, Michael; Saganas, Charalampos; Montani, Matteo; Vogt, Bruno; Huynh-Do, Uyen; Fuster, Daniel G (2021). De novo vasculitis after mRNA-1273 (Moderna) vaccination. Kidney international, 100(2), pp. 474-476. Elsevier 10.1016/j.kint.2021.05.016

Dhayat, Nasser; Faller, Nicolas; Rintelen, Felix; Roumet, Marie Camille; Irincheeva, Irina; Trelle, Sven; Tamò, Luca; Roth, Beat; Vogt, Bruno; Fuster, Daniel G (2018). Efficacy of standard and low dose hydrochlorothiazide in the recurrence prevention of calcium nephrolithiasis (NOSTONE trial): protocol for a randomized double-blind placebo-controlled trial. BMC nephrology, 19(1), p. 349. BioMed Central 10.1186/s12882-018-1144-6

Hofstetter, Willy; Siegrist, Mark; Simonin, Alexandre; Bonny, Olivier; Fuster, Daniel G (2010). Sodium/hydrogen exchanger NHA2 in osteoclasts: subcellular localization and role in vitro and in vivo. Bone, 47(2), pp. 331-340. New York, N.Y.: Elsevier 10.1016/j.bone.2010.04.605